Author:
Stukova M. A.,Zabolotnykh N. V.,Vinogradova T. I.,Gergert V. Ya.,Apt A. S.,Erokhin V. V.,Kaprelyants A. S.,Yablonskii P. K.,Kiselev O. I.
Abstract
This review is focused on recent advances in development of new vaccines for the prevention of tuberculosis. The main reasons for lack of BCG vaccine efficacy in different populations and geographic regions are presented. Design of new vaccines based on live modified strains of Mycobacterium bovis BCG, attenuated strains of Mycobacterium tuberculosis, recombinant proteins and viral vectors is considered in the specific examples. The usage of the heterologous «prime-boost» vaccination strategy against tuberculosis is discussed.
Publisher
Paediatrician Publishers LLC
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献